✦ LIBER ✦

The effect of inhaled β2-agonists on clinical outcomes in chronic obstructive pulmonary disease

✍ Scribed by Mahler, Donald A.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-Acting β2Agonists in the Management

✍ Dr Mario Cazzola, Claudio Ferdinando Donner 📂 Article 📅 2000 🏛 Springer International Publishing AG 🌐 English ⚖ 228 KB

A Benefit-Risk Assessment of Inhaled Lon

✍ Dr Milind P. Sovani, Christopher I. Whale, Anne. E. Tattersfield 📂 Article 📅 2004 🏛 Springer International Publishing AG 🌐 English ⚖ 333 KB

Systematic review of clinical outcomes i

✍ Shelley R. Salpeter; Nicholas S. Buckley 📂 Article 📅 2006 🏛 Humana Press Inc 🌐 English ⚖ 228 KB

Addition of anticholinergic solution pro

✍ David C. Levin; Katherine S. Little; Kathryn R. Laughlin; J. Mark Galbraith; Pau 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 900 KB

Short-acting inhaled beta-2-agonists inc

✍ Giovanni Corrao; Antonella Zambon; Silvia Faini; Vincenzo Bagnardi; Olivia Leoni 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 179 KB

Influence of inhaled procaterol on pulmo

✍ Hasegawa, Makoto; Dobashi, Kunio; Horie, Takeo; Wada, Naoki; Shirakura, Kenji 📂 Article 📅 2012 🏛 Elsevier 🌐 English ⚖ 364 KB